more than 100 emerging medtech companies vie

MORE THAN 100 EMERGING MEDTECH COMPANIES VIE TO PARTICIPATE
IN SEPTEMBER MEDTECH SUMMIT IN LAUSANNE
Finalists to present their companies to venture capital and investment firms
representing €10 billion in investment funding
Lausanne, Switzerland, August 24, 2010 – The European Tech Tour Association today
announced that more than 100 early and later growth stage Medtech companies are vying to
participate in the 2nd Medtech Summit to be held in Lausanne on September 29-30. During
the event, 25 selected companies will have an opportunity to present their technologies to
industry players and representatives from leading cross-border venture capital and global
investment firms representing more than €10 billion in investment capital.
“We expect the 2010 Medtech Summit to generate funding opportunities for participating
companies,” said Bill Muirhead, President of the 2010 Medtech Summit and Chairman and
co-founder of biotech company, Ayanda Biosystems. “At the last event, after the Summit
Selection Committee selected CoreValve, a cardiovascular device company, as the Medtech
Innovation award winner at the Entrepreneur of the Year ceremony, Medtronic acquired it a
few months later for US $700+ million. Several other participants also went on to secure
funding for further growth and expansion.”
This year, Medtech applicants represent 17 European countries and 12 different Medtech
industry segments. Finalists will be selected by a panel of European Medtech experts and
venture capital and investment firms in early September.
Antoine Papiernik, Managing Partner at Sofinnova Partners, commented: “The Medtech
Summit is a key forum for identifying the best emerging European Medtech technologies and
providing the investment capital to bring these technologies to market. The 2010 event is
particularly important because it comes in the wake of the recent economic crisis.
Participation in this event can help promising Medtech companies find the financial resources
that are hard to secure in this climate.”
Steve Oesterle, the Senior Vice President for Medicine and Technology from Medtronic, the
gold sponsor for the event, will deliver the keynote speech, which will also feature a visit to
their world-class medical manufacturing facility in Tolochenaz, Switzerland. Other
participating sponsors include Sofinnova, Morgan Lewis, Swiss Medtech, Canton de Vaud,
Credit Suisse, Entrepreneurs Fund, NeoMed and Valtronic Technologies.
Although applications to present at the 2010 Medtech Summit have now closed, spaces are
still available for delegates. For more information and to register, please see:
http://www.techtour.com/med2010/Overview.htm
Media contacts:
Laurian Harry
European Tech Tour
+41 22 544 60 62
[email protected]
Lukasz M. Bochenek
Genevensis Healthcare Communications
+41 22 365 99 51
[email protected]
###
About the European Tech Tour Association
The European Tech Tour Association (ETT) is an independent not-for-profit organization committed to
the development of emerging technology companies from Europe. The ETT develops European
regional Tech Tours and Vertical Industry Summits that bring together the entire technology
ecosystem of local and global players with the aim of facilitating interaction among entrepreneurs,
investors and industry players, which eventually leads to facilitating or funding local companies looking
to expand internationally. For more information, please see: http://www.techtour.com